Characteristics and outcomes of type 2 diabetes patients titrated to 60U/day with insulin glargine/lixisenatide fixed-ratio combination vs insulin in LixiLan-L Article

Web of Science: 000408315002146
Industry Collaboration

Cited authors

  • Blonde, L.; Bailey, T. S.; Chao, J.; Dex, T.; Frias, J. P.; Meneghini, L. F.; Roberts, M.; Aroda, V. R.

Publication date

  • 2017

Published in

International Standard Serial Number (ISSN)

  • 0012-186X

Start page

  • S371

End page

  • S371

Volume

  • 60